We are live on ! Find out more
BCM

Boltwood Capital Management Portfolio holdings

AUM $436M
1-Year Est. Return 24%
This Fund
S&P 500
This Quarter Est. Return
+4.89%
1 Year Est. Return
+24%
3 Year Est. Return
+56.3%
5 Year Est. Return
+58.63%
10 Year Est. Return
+204.35%
AUM
$143M
AUM Growth
+$12.1M
Cap. Flow
+$6.43M
Cap. Flow %
4.5%
Top 10 Hldgs %
31.31%
Holding
114
New
7
Increased
62
Reduced
15
Closed
2

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$876K
2
MRK icon
Merck
MRK
+$645K
3
MCK icon
McKesson
MCK
+$613K
4
PFE icon
Pfizer
PFE
+$204K
5
XRX icon
Xerox
XRX
+$185K

Sector Composition

Rank Sector Weight
1 Healthcare 15.61%
2 Financials 11.68%
3 Technology 10.98%
4 Energy 6.86%
5 Consumer Staples 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXP icon
101
Boston Properties
BXP
$11.1B
$264K 0.18%
2,000
PM icon
102
Philip Morris
PM
$295B
$252K 0.18%
+2,237
New +$231K
TROW icon
103
T. Rowe Price
TROW
$24.3B
$245K 0.17%
3,600
REZ icon
104
iShares Residential and Multisector Real Estate ETF
REZ
$879M
$227K 0.16%
3,600
WBA
105
DELISTED
Walgreens Boots Alliance
WBA
$223K 0.16%
2,693
VOX icon
106
Vanguard Communication Services ETF
VOX
$5.76B
$219K 0.15%
2,315
+300
+15% +$29.5K
GSG icon
107
iShares S&P GSCI Commodity-Indexed Trust
GSG
$968M
$212K 0.15%
14,311
+2,095
+17% +$31.9K
BIV icon
108
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$208K 0.15%
2,488
RWO icon
109
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
$208K 0.15%
+4,433
New +$209K
MCO icon
110
Moody's
MCO
$82.7B
$207K 0.14%
+1,848
New +$198K
FBIN icon
111
Fortune Brands Innovations
FBIN
$6.06B
$203K 0.14%
+3,910
New +$192K
PCAR icon
112
PACCAR
PCAR
$70.1B
$201K 0.14%
+4,500
New +$203K
MCK icon
113
McKesson
MCK
$101B
-4,365
Closed -$613K
STJ
114
DELISTED
St Jude Medical
STJ
-10,935
Closed -$876K

Similar funds

Boltwood Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Boltwood Capital Management held 114 positions worth $143M, up 9.2% from $131M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Boltwood Capital Management deployed $6.43M of net new capital in Q1 2017, opening 7 new positions and adding to 62 existing holdings. Its largest new stake was Allergan plc: 3,915 shares worth $935K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Merck, an estimated $645K trimmed.

  • Boltwood Capital Management's largest Q1 2017 buy was Allergan plc: 3,915 shares worth $935K.
  • Boltwood Capital Management added most to Abbott in Q1 2017, an estimated $575K increase.
  • Boltwood Capital Management's biggest Q1 2017 reduction was Merck, cutting an estimated $645K.
  • Boltwood Capital Management fully exited St Jude Medical in Q1 2017, selling an estimated $876K.
  • Boltwood Capital Management's ten largest holdings make up 31% of its $143M portfolio in Q1 2017.
  • Boltwood Capital Management opened 7 new positions and closed 2 in Q1 2017.
  • Boltwood Capital Management's portfolio value rose 9.2% quarter-over-quarter to $143M.

Based on Boltwood Capital Management's 13F filing for Q1 2017, filed 6 Apr 2017.